Trump and RFK Double Down on Controversial Tylenol Claims at ‘Fat Drug’ Presser: ‘The Science Hasn’t Changed!

Jennifer Bowers Bahney Nov 6th, 2025, 1:11 pm

President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on their controversial claims about Tylenol during an Oval Office press conference Thursday.

Kennedy was commenting on the Trump administration’s announcement that Americans would be getting affordable pricing on GLP-1 weight loss drugs like Ozempic and Wegovy when Trump brought up Tylenol.

“You haven’t changed your view on Tylenol for women who are pregnant?” Trump asked. “Because there are false reports out about Tylenol, Bobby changing his view. I don’t think he’s changing his view.”

“No,” Kennedy proclaimed. “I’m not going

See Full Page